SPPI(Delisted)
Spectrum Pharmaceuticals·NASDAQ
--
--(--)
SPPI fundamentals
Spectrum Pharmaceuticals (SPPI) released its earnings on Nov 2, 2017: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Nov 2, 2017
EPS
Revenue
Revenue & Expenses
SPPI has released its 2023 Q1 earnings report, with revenue of 15.62M, reflecting a YoY change of NaN%, and net profit of -5.01M, showing a YoY change of 67.58%. The Sankey diagram below clearly presents SPPI's revenue sources and cost distribution.
Key Indicators
Spectrum Pharmaceuticals (SPPI) key financial stats and ratios, covering profitability, financial health, and leverage.
Spectrum Pharmaceuticals (SPPI)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Spectrum Pharmaceuticals (SPPI)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Spectrum Pharmaceuticals (SPPI)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Spectrum Pharmaceuticals (SPPI) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Spectrum Pharmaceuticals (SPPI) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
